LYNX1 and ovarian carcinoma: Although the mechanism of nAChR signaling has not been reported for ovarian cancer, we speculate that LYNX1-related promotion of ovarian cancer cell growth may occur via modulation of α7-nAChR and activation of different intracellular signaling cascades.